Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Vm23 and Vm24, two scorpion peptides that block human T-lymphocyte potassium channels (sub-type Kv1.3) with high selectivity and decrease the in vivo DTH-responses in rats

Vm23 and Vm24, two scorpion peptides that block human T-lymphocyte potassium channels (sub-type Kv1.3) with high selectivity and decrease the in vivo DTH-responses in rats

US Patent 8394770 · Granted Mar 12, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for determining the lipid content of extracellular vesicles2025
Method for the production of lumateperone and its salts2025
Topical pharmaceutical composition containing phospholipids2024
Method for the production of lumateperone and its salts2023
Process for the preparation of polymorph form B of treprostinil diethanolamine s2022
4,6-disubstituted aminopyrimidine derivatives have anti-HIV activity2019
Dasatinib salts2018
Process for the preparation of vortioxetine salts2017
4,6-disubstituted aminopyrimidine derivatives have anti-HIV activity2017
Compounds for the treatment of ischemic injury2016
Modified peptide toxins2015
Modified peptide toxins2015